Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure. [electronic resource]
Producer: 20191227Description: H289-H297 p. digitalISSN:- 1522-1539
- Aminobutyrates -- pharmacology
- Angiotensin Receptor Antagonists -- pharmacology
- Animals
- Biphenyl Compounds
- Drug Combinations
- Drug Synergism
- Exercise Tolerance
- Fibrosis
- Heart -- drug effects
- Heart Failure -- drug therapy
- Hemodynamics
- Male
- Myocardial Contraction
- Rats
- Rats, Sprague-Dawley
- Tetrazoles -- pharmacology
- Valsartan -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.